Molecular identification of yeast communities isolated from nail specimens by PCR-RFLP and PCR-FSP methods
- PMID: 39744342
- PMCID: PMC11688582
- DOI: 10.22034/cmm.2024.345237.1539
Molecular identification of yeast communities isolated from nail specimens by PCR-RFLP and PCR-FSP methods
Abstract
Background and purpose: Onychomycosis is a common fungal infection that affects the nails, caused by various fungal agents. Moreover, yeast onychomycosis has increased in recent years. Yeast isolates might not be identified at the species level by conventional methods, whereas molecular methods can identify yeast isolates more accurately. This study aimed to identify yeast communities isolated from nail specimens by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and PCR- fragment size polymorphism (FSP) methods.
Materials and methods: This experimental study was conducted on archival yeast isolates obtained from 269 patients suspected of onychomycosis who referred to the Medical Mycology Laboratory at Shiraz University of Medical Sciences in Shiraz, Iran, between April 2022 and March 2023. Onychomycosis was confirmed through direct examination and culture of nail specimens. The PCR-RFLP and PCR-FSP methods were used to identify yeast isolates.
Results: In total, 78 (28.99%) yeast strains were identified. Candida albicans was the most common species, followed by Candida parapsilosis complex and Candida tropicalis. Uncommon species of yeasts, such as Candida utilis, Candida pararugosa, Candida nivariensis, and Rhodotorula rubra were identified by molecular methods. The PCR-FSP method showed a strong agreement with the PCR-RFLP method in the identification of common yeast agents causing onychomycosis (κ=0.84).
Conclusion: It seems necessary to use molecular diagnostic tools in addition to conventional methods to identify yeast isolates in clinical laboratories. The rapid and accurate identification of fungal agents causing onychomycosis is useful for the selection of an appropriate treatment strategy.
Keywords: Molecular identification; Onychomycosis; PCR-FSP; PCR-RFLP; Yeast communities.
Copyright: © 2021, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
Species distribution and antifungal susceptibility profiles of yeasts isolated from onychomycosis: a cross-sectional study with insights into emerging species.Antonie Van Leeuwenhoek. 2023 Dec 28;117(1):6. doi: 10.1007/s10482-023-01914-0. Antonie Van Leeuwenhoek. 2023. PMID: 38153531
-
Comparison of CHROMagar, polymerase chain reaction-restriction fragment length polymorphism, and polymerase chain reaction-fragment size for the identification of Candida species.Curr Med Mycol. 2017 Sep;3(3):10-15. doi: 10.29252/cmm.3.3.10. Curr Med Mycol. 2017. PMID: 29707668 Free PMC article.
-
Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis.Adv Biomed Res. 2015 May 11;4:95. doi: 10.4103/2277-9175.156659. eCollection 2015. Adv Biomed Res. 2015. PMID: 26015921 Free PMC article.
-
[Etiopathogenesis, clinical picture and diagnosis of onychomycoses].Med Pregl. 2001 Jan-Feb;54(1-2):45-51. Med Pregl. 2001. PMID: 11432322 Review. Croatian.
-
Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis.J Mycol Med. 2018 Dec;28(4):651-654. doi: 10.1016/j.mycmed.2018.07.005. Epub 2018 Aug 11. J Mycol Med. 2018. PMID: 30107987 Review.
Cited by
-
Molecular identification and antifungal susceptibility profile of rare and emerging yeast species causing onychomycosis.BMC Res Notes. 2025 Apr 14;18(1):167. doi: 10.1186/s13104-025-07197-0. BMC Res Notes. 2025. PMID: 40229655 Free PMC article.
References
-
- Zaraa I, Dehavay F, Richert B. Onychomycosis. Hand Surg Rehabil. 2024:101638. - PubMed
-
- Giri Y, Habibullah S, Dixit PK, Mahalik G, Mohanty B, Behera A. Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management. Colloids and Surfaces B: Biointerfaces. 2024;234:113718. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous